Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Fluoroisatoic anhydride, with the molecular formula C8H3F3O4, is a white crystalline solid that serves as a crucial chemical compound in the realm of organic synthesis and pharmaceutical research. Characterized by its high reactivity, this versatile building block is instrumental in the production of a wide array of compounds, particularly in the synthesis of complex molecules for various applications. Despite its utility, 3-Fluoroisatoic anhydride is classified as a hazardous chemical, necessitating careful handling by trained professionals within a controlled laboratory environment to avoid skin, eye, and respiratory irritation.

174463-53-7

Post Buying Request

174463-53-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

174463-53-7 Usage

Uses

Used in Pharmaceutical Research:
3-Fluoroisatoic anhydride is utilized as a key intermediate in the development of new pharmaceuticals, leveraging its reactivity to facilitate the synthesis of diverse medicinal compounds. Its role in drug discovery is pivotal, as it can be incorporated into the molecular structures of potential therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Fluoroisatoic anhydride is employed as a reagent for the production of various organic compounds. Its ability to participate in multiple chemical reactions makes it an indispensable component in the creation of specialty chemicals and advanced materials.
Used in Chemical Research:
3-Fluoroisatoic anhydride also serves as a valuable tool in chemical research, where its unique properties are explored to understand reaction mechanisms and develop innovative synthetic pathways. This contributes to the advancement of chemical knowledge and the discovery of new chemical processes.
Used in the Production of Compounds:
3-Fluoroisatoic anhydride is used as a precursor in the synthesis of a variety of compounds, including those with potential applications in materials science, agrochemicals, and other industries. Its versatility in undergoing different types of chemical reactions makes it a sought-after component in the creation of new and improved products.

Check Digit Verification of cas no

The CAS Registry Mumber 174463-53-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,4,6 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 174463-53:
(8*1)+(7*7)+(6*4)+(5*4)+(4*6)+(3*3)+(2*5)+(1*3)=147
147 % 10 = 7
So 174463-53-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H4FNO3/c9-5-3-1-2-4-6(5)10-8(12)13-7(4)11/h1-3H,(H,10,12)

174463-53-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 8-fluoro-1H-3,1-benzoxazine-2,4-dione

1.2 Other means of identification

Product number -
Other names 3-Fluoroisatoicanhydride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:174463-53-7 SDS

174463-53-7Relevant articles and documents

Nitrogen-containing ring derivative inhibitor as well as preparation method and application thereof

-

Paragraph 0555-0561, (2021/05/12)

The invention relates to a nitrogen-containing ring derivative inhibitor as well as a preparation method and an application thereof. In particular, the present invention relates to a compound represented by general formula (I), a preparation method thereof, a pharmaceutical composition containing the compound, and uses of the compound as a P2X3 inhibitor in treatment of P2X3 receptor dysfunction diseases, especially in treatment of neurogenic diseases.

Synthesis of Ring-Fused, N-Substituted 4-Quinolinones Using p Ka-Guided, Base-Promoted Annulations with Isatoic Anhydrides: Total Synthesis of Penicinotam

Khalifa, Muhammad M.,Philkhana, Satish Chandra,Golden, Jennifer E.

, p. 464 - 481 (2019/12/24)

An anionic annulation strategy employing isatoic anhydrides and a wide assortment of enolizable partners was developed to afford over 80 novel ring-fused, N-substituted 4-quinolinones, an underrepresented privileged template. Multiple factors governing the efficiency of the transformation were determined, resulting in a reliable and tunable synthetic platform applicable for a broad range of substrates with variable deprotonation susceptibility, such as tetramic and tetronic acids, cyclic 1,3-diketones, and cycloalkanones. Application to the synthesis of bioactive, pyrrolizine-fused 4-quinolinone, penicinotam 3, resulted in the most brief and highest yielding total synthesis of the alkaloid in three steps and a 36% overall yield.

Target Elucidation by Cocrystal Structures of NADH-Ubiquinone Oxidoreductase of Plasmodium falciparum (PfNDH2) with Small Molecule To Eliminate Drug-Resistant Malaria

Yang, Yiqing,Yu, You,Li, Xiaolu,Li, Jing,Wu, Yue,Yu, Jie,Ge, Jingpeng,Huang, Zhenghui,Jiang, Lubin,Rao, Yu,Yang, Maojun

supporting information, p. 1994 - 2005 (2017/03/17)

Drug-resistant malarial strains have been continuously emerging recently, which posts a great challenge for the global health. Therefore, new antimalarial drugs with novel targeting mechanisms are urgently needed for fighting drug-resistant malaria. NADH-ubiquinone oxidoreductase of Plasmodium falciparum (PfNDH2) represents a viable target for antimalarial drug development. However, the absence of structural information on PfNDH2 limited rational drug design and further development. Herein, we report high resolution crystal structures of the PfNDH2 protein for the first time in Apo-, NADH-, and RYL-552 (a new inhibitor)-bound states. The PfNDH2 inhibitor exhibits excellent potency against both drug-resistant strains in vitro and parasite-infected mice in vivo via a potential allosteric mechanism. Furthermore, it was found that the inhibitor can be used in combination with dihydroartemisinin (DHA) synergistically. These findings not only are important for malarial PfNDH2 protein-based drug development but could also have broad implications for other NDH2-containing pathogenic microorganisms such as Mycobacterium tuberculosis.

Isatoic anhydride and its process for synthesis of derivatives of

-

Paragraph 0048; 0049; 0050; 0051; 0052; 0053; 0054, (2017/01/12)

The invention discloses a synthesis method of isatoic anhydride and a derivative thereof, relating to the technical field of chemical synthesis. In the presence of catalysis of an organic selenium catalyst, isatin or a derivative thereof is oxidized by using hydrogen peroxide to prepare the isatoic anhydride and the derivative thereof. The synthesis method disclosed by the invention is simple and easily available in raw materials, low in cost, clean in oxidizing agent, free from a metal catalyst, and environmentally friendly, can be carried out in a neutral environment, and is small in corrosion to equipment.

Is the 2,3-carbon-carbon bond of indole really inert to oxidative cleavage by Oxone?-Synthesis of isatoic anhydrides from indoles

Nelson, Amber C.,Kalinowski, Emily S.,Czerniecki, Nikolas J.,Jacobson, Taylor L.,Grundt, Peter

supporting information, p. 7455 - 7457 (2013/11/06)

A recent report has indicated that the oxidizing agent Oxone does not possess the ability to cleave the 2,3-carbon-carbon bond of indole. Work in our laboratory shows that this is not the case. Indole and a variety of aryl ring substituted derivatives readily react to form synthetically important isatoic anhydrides.

Structure-activity relationships of a series of substituted benzamides: Potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents

Norman, Mark H.,Rigdon, Greg C.,Hall, William R.,Navas III, Frank

, p. 1172 - 1188 (2007/10/03)

A series of substituted (4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)benzamide derivatives was prepared and evaluated as potential atypical antipsychotic agents. The target compounds were readily prepared from their benzoyl chloride, benzoic acid, or isatoic anhydride precursors, and they were evaluated in vitro for their ability to bind to dopamine D2, serotonin 5-HT2, and serotonin 5-HT1a receptors. To assess the potential antipsychotic activity of these compounds, we investigated their ability to inhibit the apomorphine-induced climbing response in mice. Selected compounds were evaluated further to determine their side-effect potentials. Structure-activity relationships of both mono- and polysubstituted benzamides are discussed herein. While several analogues had potent in vitro and in vivo activities indicative of potential atypical antipsychotic activity, anthranilamide 77 (1192U90) demonstrated a superior pharmacological profile. As a result of this investigation, 1192U90 (2-amino-N-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)benzamide hydrochloride) was selected for further evaluation and is currently in phase I clinical trials as a potential atypical antipsychotic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 174463-53-7